CVS vs IRD · P/E 16, rev $402.07B vs rev $11.0M
CVS Health Corp (CVS) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. IRD currently screens at market cap $35.7M.
Not investment advice. Open the CVS and IRD stock pages for the full models.
Not investment advice.